Navid Redjal, MD, FAANS

Dr. Navid Redjal has joined the Cooper Neuroscience Institute as the Director of Surgical Neuro-oncology. Dr. Redjal currently serves as Director of Neurosurgical Oncology at Capital Health System and will provide surgical neuro-oncology care at both campuses, further enhancing the existing collaboration in clinical neuroscience between Cooper University Care and Capital Health. At Cooper, he joins the Neurosurgery team in building a neuro-oncology center of excellence with a focus on the highest quality patient care in combination with cutting edge treatment and exciting clinical trials.
 
Dr. Navid Redjal is a board certified neurosurgeon specializing in the treatment of brain tumors with extensive research and clinical background in neuro-oncology. Dr. Redjal graduated from Harvard Medical School with honors, specifically completing the Harvard-MIT Health Sciences and Technology Society curriculum with research thesis focusing on targeted therapeutics for brain cancer with a post-doctoral research fellowship at the Dana Farber Cancer Institute. After completing medical school, he did his residency at the Massachusetts General Hospital/Harvard neurosurgery program where he also did an enfolded fellowship in stereotactic radiosurgery. He specializes in complex brain surgery including awake surgery, language and motor mapping, minimally invasive neuro-endoscopic surgery utilizing detailed MRI-based neuro-navigation with diffuse tensor imaging and intraoperative ultrasound. He also uses stereotactic radiosurgery in collaboration with radiation oncologists to treat a variety of brain and spine tumors.